MicroRNA-20a-5p inhibits epithelial to mesenchymal transition and invasion of endometrial cancer cells by targeting STAT3.
暂无分享,去创建一个
[1] W. Peng,et al. STAT3 activation by IL-6 from adipose-derived stem cells promotes endometrial carcinoma proliferation and metastasis. , 2018, Biochemical and biophysical research communications.
[2] Ming-jun Sun,et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR‐20a‐5p/HMGA2 axis in breast cancer , 2018, Cancer medicine.
[3] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[4] S. Biffo,et al. Role of microRNAs in translation regulation and cancer , 2017, World journal of biological chemistry.
[5] P. Goodfellow,et al. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target , 2017, Oncogene.
[6] M. Sherman,et al. High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database , 2016, International journal of cancer.
[7] K. Torres,et al. Erratum to: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer , 2016, BMC Cancer.
[8] T. Song,et al. MicroRNA-20a-5p targets RUNX3 to regulate proliferation and migration of human hepatocellular cancer cells. , 2016, Oncology reports.
[9] Xi Chen,et al. MicroRNA-93 Promotes Epithelial–Mesenchymal Transition of Endometrial Carcinoma Cells , 2016, PloS one.
[10] George A. Calin,et al. microRNA Therapeutics in Cancer — An Emerging Concept , 2016, EBioMedicine.
[11] H. Mackay,et al. Endometrial cancer: Not your grandmother's cancer , 2016, Cancer.
[12] M. Burchardt,et al. The future therapy of endometrial cancer: microRNA’s functionality, capability, and putative clinical application , 2016, Archives of Gynecology and Obstetrics.
[13] E. Darai,et al. Endometrial cancer , 2016, The Lancet.
[14] I. G. Reed,et al. Regulation of epithelial–mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs , 2016, Clinical and Translational Oncology.
[15] Meenakshi Singh,et al. Endometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical Dilemmas. , 2016, American journal of clinical pathology.
[16] E. Kimura,et al. Insights into Regulation of the miR-17-92 Cluster of miRNAs in Cancer , 2015, Front. Med..
[17] N. Nikitakis,et al. STAT3 Signaling in Cancer , 2015 .
[18] D. Levy,et al. STAT3 regulated ARF expression suppresses prostate cancer metastasis , 2015, Nature Communications.
[19] A. Zaravinos. The Regulatory Role of MicroRNAs in EMT and Cancer , 2015, Journal of oncology.
[20] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[21] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[22] S. Baka,et al. The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review , 2015, Archives of Gynecology and Obstetrics.
[23] M. Goel,et al. Tumor progression, metastasis and modulators of EMT in endometrioid endometrial , 2015 .
[24] Ming Zhou,et al. MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1 , 2014, Cancer biology & therapy.
[25] L. Pfeffer,et al. Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer , 2014, Breast Cancer Research and Treatment.
[26] R. Lai,et al. STAT3 in Cancer—Friend or Foe? , 2014, Cancers.
[27] Tong Li,et al. miR‐20a Promotes Prostate Cancer Invasion and Migration Through Targeting ABL2 , 2014, Journal of cellular biochemistry.
[28] P. Dong,et al. MicroRNA‐106b modulates epithelial–mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines , 2014, Molecular carcinogenesis.
[29] K. Hong,et al. miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3 , 2013, Molecular and Cellular Biochemistry.
[30] D. Aoki,et al. MicroRNAs in endometrial cancer , 2013, International Journal of Clinical Oncology.
[31] Shih-Chieh Lin,et al. Hypoxia-induced microRNA-20a expression increases ERK phosphorylation and angiogenic gene expression in endometriotic stromal cells. , 2012, The Journal of clinical endocrinology and metabolism.
[32] Jie Xiang,et al. Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis , 2010, Current genomics.
[33] R. Agami,et al. Tumorigenicity of the miR-17-92 cluster distilled. , 2010, Genes & development.
[34] J. Mendell. miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.
[35] J. Lin,et al. Stat3 activation in human endometrial and cervical cancers , 2007, British Journal of Cancer.